Abstract:Xuefeng Bian, 1, &ast Ting Guo, 2, &ast Guojie Chen, 2, &ast Dengyun Nie, 2 Miao Yue, 2 Yinxing Zhu, 2 Mei Lin 3 1 Imaging Department, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China; 2 Institute of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China; 3 Clinical Medical Laboratory, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Mei Lin; Yinxing Zhu, Email ; Purpose: This study aimed to construct targeting drug-loading nanocomposites (FA-FePt/DDP nanoliposomes) to explore their potential in ovarian cancer therapy and molecular magnetic resonance imaging (MMRI). Methods: FA-FePt-NPs were prepared by coupling folate (FA) with polyethylene-glycol (PEG)-coated ferroplatinum nanoparticles and characterized. Then cisplatin (DDP) was encapsulated in FA-FePt-NPs to synthesize FA-PEG-FePt/DDP nanoliposomes by thin film-ultrasonic method and high-speed stirring, of which MMRI potential, magnetothermal effect, and the other involved performance were analyzed. The therapeutic effect of FA-FePt/DDP nanoliposomes combined with magnetic fluid hyperthermia (MFH) on ovarian cancer in vitro and in vivo was evaluated. The expression levels of Bax and epithelial–mesenchymal transition related proteins were detected. The biosafety was also preliminarily observed. Results: The average diameter of FA-FePt-NPs was about 30 nm, FA-FePt/DDP nanoliposomes were about 70 nm in hydrated particle size, with drug slow-release and good cell-specific targeted uptake. In an alternating magnetic field (AMF), FA-FePt/DDP nanoliposomes could rapidly reach the ideal tumor hyperthermia temperature (42~44 °C). MRI scan showed that FA-FePt-NPs and FA-FePt/DDP nanoliposomes both could suppress the T2 signal, indicating a good potential for MMRI. The in vitro and in vivo experiments showed that FA-FePt/DDP-NPs in AMF could effectively inhibit the growth of ovarian cancer by inhibiting cancer cell proliferation, invasion, and migration, and inducing cancer cell apoptosis, much better than that of the other individual therapies; molecularly, E-cadherin and Bax proteins in ovarian cancer cells and tissues were significantly increased, while N-cadherin, Vimentin, and Bcl-2 proteins were inhibited, effectively inhibiting the malignant progression of ovarian cancer. In addition, no significant pathological injury and dysfunction was observed in major visceras. Conclusion: We successfully synthesized FA-FePt/DDP nanoliposomes and confirmed their good thermochemotherapeutic effect in AMF and MMRI potential on ovarian cancer, with no obvious side effects, providing a favorable strategy of integrated targeting therapy and diagnosis for ovarian cancer. Keywords: iron–platinum magnetic nanoparticles, ovarian cancer, DDP, molecular magnetic resonance imaging, folate As one of the common tumors in the female reproductive system, ovarian cancer lists first among gynecological tumors in mortality. 1 Although considerable progress has been made, the diagnosis and therapy of ovarian cancer are not satisfactory. Up to the present, the pathological examination remains the gold standard for the diagnosis of ovarian cancer; however, the process is invasive and it is difficult to detect the tumor tissue in non-surgery. 2 Surgery combined with chemotherapy is considered the routine method for the treatment of ovarian cancer, 3 but most patients are at advanced stage and lose the best chance of surgery because of ovarian cancer concealment. Concurrently, most of the current medications are administered intravenously and have non-selectivity of cancer tissue. As a result, it is difficult for the anti-tumor medicine to maintain high concentration in the lesion location, leading to poor efficacy and severe side effects. 4,5 Therefore, it is in great demand to seek a non-invasive, safe, sensitive, and accurate diagnosis method and effective therapy with less adverse effects for ovarian cancer. Magnetic resonance imaging (MRI), an extensively applied non-invasive medical diagnostic technology at present, has unique advantages in the diagnosis of various tumors, such as liver cancer, cervical cancer, ovarian cancer, glioma, and other tumors, due to its hi -Abstract Truncated-

Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer

Abstract B045: In vivo ovarian cancer detection using folate receptor-α targeted iron oxide nanoparticles

Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging.

Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo

The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer

Decorated of Au NPs over L-arginine-modified Fe3O4 nanoparticles as a novel nanomagnetic composite for the treatment of human ovarian cancer

Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.

Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in Ovarian Cancer

Targeted molecular imaging of antigen OC183B2 in ovarian cancers using MR molecular probes.

Highly Efficient Synergistic Chemotherapy and Magnetic Resonance Imaging for Targeted Ovarian Cancer Therapy Using Hyaluronic Acid‐Coated Coordination Polymer Nanoparticles

Aptamer-Modified Zinc Ferrite Nanoparticles for Autophagy-Mediated Chemotherapy and MR Imaging of Ovarian Cancer

Using PEGylated Iron Oxide Nanoparticles with Ultrahigh Relaxivity for MR Imaging of an Orthotopic Model of Human Hepatocellular Carcinoma

2-Deoxy-d-glucose Modified Supermagnetic Iron Oxide Nanoparticles Enhance the Contrasting Effect on MRI of Human Lung Adenocarcinoma A549 Tumor in Nude Mice

Preparation and in vitro MR imaging of folic acid-conjuncted APTMS coated ultrasmall superparamagnetic iron oxide

Ferric Oxide Nanoparticles Enhance Cytotoxicity and Reduce the Occurrence and Development of Cervical Cancer Metastases

LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated via spectral photon-counting CT imaging: a proof-of-concept research

In Vivo Targeted Magnetic Resonance Imaging and Visualized Photodynamic Therapy in Deep-Tissue Cancers Using Folic Acid-Functionalized Superparamagnetic-Upconversion Nanocomposites

In Vitro and in Vivo Targeting Magnetic Resonance Imaging for Ovaran Cancer by Anti-Human Sperm Protein 17 Mediated Magnetic Nanoprobes

Functionalized Iron Oxide Nanoparticles for Both Dual-Modal Imaging and Erythropoiesis

In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy